ADVERTISEMENT

Conference Report

ESMO 2022 – Why are some cancers so hard to treat?

Elena Riboldi — Agenzia Zoe   |   13 September 2022

Takeaway

  • The study of tumour heterogeneity explains why some cancers are especially aggressive and resistant to treatment.
  • Knowledge of tumour biology and clinical trial optimization will help to reduce hard-to-treat cancer mortality.

“Why is cancer the emperor of all maladies? One of the key answers is because cancer development is...

          

November Challenge

Ends in 1d 7h
left
right

Topic Challenges

left
right